CLINICAL_TRIALS
trial_result
· 2026-03-31
Clinical Trial Update: Safety of Bryostatin in Patients With MS [Phase 1]
Summary
A Phase 1 safety trial evaluating Bryostatin in people with multiple sclerosis was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Robert Fox | Conditions: Multiple Sclerosis | Phase 1 | Status: TERMINATED | Results posted: 2026-03-31